| Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia (NCT07473843) | Arrowhead Pharmaceuticals | 2026-08-01 |
| A First-In-Human Study of ARO-033 in Adult Participants (NCT07662096) | Arrowhead Pharmaceuticals | 2026-06-25 |
| Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma (NCT07241546) | Arrowhead Pharmaceuticals | 2026-03-30 |
| Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia (NCT07223658) | Arrowhead Pharmaceuticals | 2025-12-22 |
| Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease (NCT07221344) | Arrowhead Pharmaceuticals | 2025-11-18 |
| A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE) (NCT07037771) | Arrowhead Pharmaceuticals | 2025-06-17 |
| A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus (NCT06937203) | Arrowhead Pharmaceuticals | 2025-05-09 |
| Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia (NCT06822790) | Arrowhead Pharmaceuticals | 2025-04-09 |
| Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 (NCT06672445) | Arrowhead Pharmaceuticals | 2024-12-17 |
| A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus (NCT06700538) | Arrowhead Pharmaceuticals | 2024-12-04 |
| Study of Plozasiran in Adults With Severe Hypertriglyceridemia (NCT06347016) | Arrowhead Pharmaceuticals | 2024-07-23 |
| Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia (NCT06347003) | Arrowhead Pharmaceuticals | 2024-07-22 |
| Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia (NCT06347133) | Arrowhead Pharmaceuticals | 2024-05-21 |
| Study of ARO-CFB in Adult Healthy Volunteers (NCT06209177) | Arrowhead Pharmaceuticals | 2024-04-05 |
| Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS) (NCT05949294) | Arrowhead Pharmaceuticals | 2024-01-01 |
| Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis (NCT05537025) | Arrowhead Pharmaceuticals | 2023-01-30 |
| Study of ARO-RAGE in Healthy Subjects (NCT05533294) | Arrowhead Pharmaceuticals | 2022-11-29 |
| Study of ARO-APOC3 in Adults With Dyslipidemia (NCT05413135) | Arrowhead Pharmaceuticals | 2022-07-07 |
| Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease (NCT05276570) | Arrowhead Pharmaceuticals | 2022-06-29 |
| Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease (NCT05292950) | Arrowhead Pharmaceuticals | 2022-06-27 |
| Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH) (NCT05217667) | Arrowhead Pharmaceuticals | 2022-04-22 |
| Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease (NCT05083364) | Arrowhead Pharmaceuticals | 2022-02-01 |
| Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) (NCT05089084) | Arrowhead Pharmaceuticals | 2021-12-14 |
| Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia (NCT04998201) | Arrowhead Pharmaceuticals | 2021-09-28 |
| Study of ARO-ANG3 in Adults With Mixed Dyslipidemia (NCT04832971) | Arrowhead Pharmaceuticals | 2021-06-28 |
| Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia (NCT04720534) | Arrowhead Pharmaceuticals | 2021-05-31 |
| Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma (NCT04169711) | Arrowhead Pharmaceuticals | 2020-08-17 |
| Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis (NCT04375514) | Arrowhead Pharmaceuticals | 2020-07-30 |
| Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) (NCT03945292) | Arrowhead Pharmaceuticals | 2019-08-07 |
| Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS) (NCT03783377) | Arrowhead Pharmaceuticals | 2019-03-08 |
| Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients (NCT03747224) | Arrowhead Pharmaceuticals | 2019-01-07 |
| Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) (NCT03365947) | Arrowhead Pharmaceuticals | 2018-03-27 |
| Study of ARO-AAT in Normal Adult Volunteers (NCT03362242) | Arrowhead Pharmaceuticals | 2018-03-12 |